One of the studies revealed that in women with polycystic ovary syndrome and hyperprolactinemia who were receiving metformin, the addition of probiotics to metformin therapy significantly reduced prolactin levels compared to metformin therapy alone [43]. This evidence concerns the gene PRL and polycystic ovary syndrome.